Results 301 to 310 of about 418,262 (333)

Induction of Apoptosis by Cancer Chemotherapy

Experimental Cell Research, 2000
Studies performed over the past five years have demonstrated that there are two major cell-intrinsic pathways for inducing apoptosis, one that begins with ligation of cell surface death receptors and another that involves mitochondrial release of cytochrome c.
S H, Kaufmann, W C, Earnshaw
openaire   +2 more sources

Induction Chemotherapy for Advanced Oral Cavity Cancer

Current Oncology Reports, 2021
Head and neck cancer is a heterogeneous disease, comprising multiple subsites with diverse etiologic factors, pathology and molecular features, response to treatment, and prognosis. Systemic treatment is usually incorporated in the management of locally advanced head and neck squamous cell carcinoma, and the use of induction chemotherapy has ...
Thiago Bueno de Oliveira, Gustavo Nader Marta, Gilberto de Castro Junior, Luiz Paulo Kowalski   +3 more
openaire   +2 more sources

Intra-arterial induction chemotherapy

Oncology Reports, 1996
When effective anti-cancer drugs first became available to clinicians they were commonly used by surgeons by intra-arterial infusion to treat difficult regional cancer problems. Because they were most often used to treat poorly vascularised recurrent cancers results were, in general, unsatisfactory.
openaire   +2 more sources

Organ Preservation-Induction Chemotherapy

2006
Induction chemotherapy consisting of high dose cisplatin and infusional 5-FU (PF) followed by definitive radiation therapy for the past decade has been the organ-sparing alternative to surgery for patients with laryngeal and hypopharyngeal squamous cell carcinomas.
openaire   +2 more sources

Neutrophilic eccrine hidradenitis associated with induction chemotherapy

Journal of Cutaneous Pathology, 1987
We report three new cases of neutrophilic eccrine hidradenitis associated with induction chemotherapy which resolves two major points. First, because two of our patients had testicular carcinoma; this firmly establishes that NEH is not exclusively seen in patients with acute myelogenous leukemia or Hodgkin's lymphoma as previously reported.
J E, Fitzpatrick, S D, Bennion, O M, Reed, T, Wilson, V V, Reddy, L, Golitz   +5 more
openaire   +2 more sources

Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma

Oral Oncology, 2020
Induction chemotherapy plus concurrent chemoradiotherapy (IC + CCRT) is a standard treatment regimen for locally advanced nasopharyngeal carcinoma (LA-NPC). However, the increased acute toxicity of this intensified chemotherapy may counteract its efficacy.
Qiaoli Wang, Guoqiang Xu, Yaoxiong Xia, Jia Zuo, Guilin Zeng, Zhihong Xue, Ruixue Cao, Wei Xiong, Wenhui Li   +8 more
openaire   +2 more sources

Induction Chemotherapy for Cervical Cancer

2011
The standard of care in advanced cervical cancer in all stages from and above IB2 with tumors larger than 4 cm in diameter to stage IVA with invasion of the bladder or/and rectum is radiochemotherapy. In this setting intracavitary brachytherapy is the most active component for local tumor eradication and favourable long-term results.
Karl Reinhard Aigner, Josef Jansa
openaire   +1 more source

Chemotherapy for Thymic Tumors: Induction, Consolidation, Palliation

Thoracic Surgery Clinics, 2011
Although thymoma and thymic carcinoma are rare malignancies, they constitute a large proportion of tumors of the anterior mediastinum. Surgery forms the mainstay of therapy; however, thymic malignancies are sensitive to chemotherapy and radiation therapy also.
Arun, Rajan, Giuseppe, Giaccone
openaire   +2 more sources

Induction chemotherapy using intraarterial infusion

1991
Until recently gastrectomy was the only treatment offering any real prospect of cure for patients with gastric cancer. However, excepting patients with minimal disease, the results of gastrectomy alone have been unsatisfactory, whether the gastrectomy has been total or subtotal.
openaire   +2 more sources

Induction Chemotherapy for Hepatocellular Carcinoma

2011
Hepatocellular carcinoma (HCC) is known as a relatively chemoresistant tumor, and systemic cytotoxic chemotherapy has failed to show a substantial benefit for patients with HCC. Other systemic therapies including hormonal therapy and immunotherapy have also been disappointing.
Takumi Fukumoto, Yonson Ku
openaire   +1 more source